MyFinsight
Home
Blog
About
Contact
Proceeds from line of
credit
$5,068K
Proceeds from issuance of
common stock under...
$21K
Net cash provided by
(used in) financing...
$3,981K
Effect of exchange rate
changes on cash and cash...
$646K
Canceled cashflow
$1,108K
Net (decrease) in
cash and cash...
-$25,188K
Canceled cashflow
$4,627K
Proceeds from maturities
of marketable...
$70,714K
Proceeds from sale of
property and equipment
$6K
Trade accounts
receivable
-$9,645K
Stock-based compensation
$4,861K
Prepaid expenses and
other assets
-$3,853K
Operating lease
liabilities
$3,117K
Depreciation and
amortization
$1,865K
Deferred revenue
$1,175K
Amortization of operating
lease-right-of use assets
$948K
Provision for credit
losses
$459K
Trade accounts
payable
$390K
Other non-cash
expense (income), net
-$236K
Provision for excess and
obsolete inventory
$193K
Loss on disposal of
property and equipment
-$55K
Repayment of loan
$869K
Payments for taxes
related to net share...
$239K
Net cash (used in)
provided by investing...
-$27,079K
Canceled cashflow
$70,720K
Net cash (used in)
operating activities
-$2,736K
Canceled cashflow
$26,797K
Cost of sales
(excluding stock-based...
-$41,548K
General and
administrative (excluding...
-$18,062K
Sales (excluding
stock-based compensation)
-$15,833K
Research and development
(excluding stock-based...
-$14,760K
Stock-based compensation
expense
-$14,198K
Marketing (excluding
stock-based compensation)
-$6,168K
Amortization - license & ip
expense
-$974K
Purchases of marketable
securities
-$95,598K
Purchase of property and
equipment
$2,168K
Purchase of intangible
assets
$33K
Net loss
-$18,866K
Canceled cashflow
$111,543K
Accrued expenses and
other liabilities
-$3,890K
something is missing
-$3,276K
Inventories
$1,627K
Gain on investments,
accretion, and...
-$1,255K
Legal settlement
liabilities
-$389K
Deferred income taxes
-$183K
Interest expenses for
accretion of the legal...
-$47K
Total revenue, net
-$95,217K
something is missing
-$22,463K
Other segment items
$12,729K
Back
Back
Cash Flow
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)
source: myfinsight.com